Kestra Investment Management, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1962449
AUSTIN, TX
Position in MDGL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$240,796
-$18,345 QoQ
Shares Held
460
+3.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Investment Management, LLC holds $5,070,571 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
31,530 | $1,715,547 | |
| 2 | INCY |
Incyte Corp
|
12,148 | $1,377,097 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,618 | $788,096 | |
| 4 | RPRX |
Royalty Pharma plc
|
7,788 | $436,673 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
659 | $410,912 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
689 | $342,246 |
All Filings in MDGL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240,796 | 460 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $259,141 | 445 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $202,727 | 442 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $84,739 | 280 | Shares | Sole | 2025-08-18 | |
| No filing history on record for this holder in this stock. | ||||||